Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Other Operating Expenses (2018 - 2024)

Avai Bio's Other Operating Expenses history spans 6 years, with the latest figure at $603084.0 for Q1 2024.

  • For Q1 2024, Other Operating Expenses changed N/A year-over-year to $603084.0; the TTM value through Mar 2024 reached $691268.0, up 2026.85%, while the annual FY2025 figure was $769457.0, 11.53% up from the prior year.
  • Other Operating Expenses for Q1 2024 was $603084.0 at Avai Bio, up from $27195.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $603084.0 in Q1 2024 and bottomed at $9.0 in Q4 2020.
  • The 4-year median for Other Operating Expenses is $12793.0 (2022), against an average of $68974.4.
  • The largest annual shift saw Other Operating Expenses tumbled 99.5% in 2020 before it surged 1184.8% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at $9.0 in 2020, then soared by 142044.44% to $12793.0 in 2022, then soared by 112.58% to $27195.0 in 2023, then soared by 2117.63% to $603084.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Other Operating Expenses are $603084.0 (Q1 2024), $27195.0 (Q4 2023), and $11293.0 (Q3 2023).